Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10
Original Research
Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,047 | Dovepress* | 2,819+ | 72 | 2,891 | |
| PubMed Central* | 228 | 113 | 341 | ||
| Totals | 3,047 | 185 | 3,232 | ||
| *Since 27 February 2023 | |||||
View citations on PubMed Central and Google Scholar